INFLUENCE OF OZONE THERAPY IN
Chief Physician, Augusta Klinik
6550 Bad Kreuznach, F.R.G.
The treatment of patients with rheumatoid arthritis is a challenge for rheumatologists.
Several clinical studies have shown that anti-malarial agents, gold salts, Methotrexat, and some cytotoxicagents have disease-modifying properties, but response to treatment with these drugs is variable and acertain proportion of the RA patients do not benefit.
O3 / O2 has a potent immunomodulator capable of selective modulation of
subpopulations of immunocompetent cells. This properties suggested that ozone useful of treatment of RA.
Clinical efficacy was observed one month after the beginning of treatment, was well established after many months of therapy, and remained stable for the remainder of the one-year treatment period.
It is known that ozone administration in different applications forms for the time
between 6 to 8 weeks cause improvement of the general condition of the patients
(clinically and biochemically).
Concluded that ozone is clinically effective for the treatment of patients with refractory RA, but its value for intervention therapy is limited.
Publish Date: 1991